| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |